CYPH — CYPHERPUNK TECHNOLOGIES INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1509745 ·
Last close
$0.59
Market Cap
$62.92M
52W High
$1.40
52W Low
$0.49
ADV30
1,839,097
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,817,000 | -77,166,000 | 87,378,000 | 6,689,000 | 3,003,000 |
| Dec 2025 | 0 | — | -5,260,000 | 40,203,000 | 163,182,000 | 14,035,000 | 9,676,000 |
| Sep 2025 | 0 | — | -3,222,000 | -3,303,000 | 11,399,000 | 9,686,000 | 8,704,000 |
| Jun 2025 | 0 | — | -12,353,000 | -16,643,000 | 20,042,000 | 18,130,000 | 14,325,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-32,852,000
Investing CF
$-9,000,000
Financing CF
$112,785,000
CapEx
$-4,000,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.31
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-539,715,000
Inventory
—
Receivables
$74,465,000
ST Investments
—
EBIT TTM
$-56,747,000
Pretax Income TTM
$-56,772,000
Interest Exp TTM
$25,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -36,697,000 | 4,822,000 | 163,182,000 | 9,676,000 | — | -43,902,000 |
| Dec 2024 | 0 | -70,057,000 | -67,555,000 | 49,124,000 | 14,076,000 | — | -60,299,000 |
| Dec 2023 | 0 | -85,940,000 | -81,414,000 | 72,825,000 | 12,684,000 | — | -43,753,000 |
| Dec 2022 | 0 | -54,712,000 | -54,596,000 | 70,353,000 | 11,487,000 | — | -49,044,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.09
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZYBT | Zhengye Biotechnology Holding Ltd | $63.03M | $1.33 | — |
| RNTX | Rein Therapeutics, Inc. | $63.04M | $0.74 | — |
| CLNN | Clene Inc. | $64.15M | $5.02 | — |
| ACRV | Acrivon Therapeutics, Inc. | $64.20M | $1.50 | — |
| PLRX | PLIANT THERAPEUTICS, INC. | $64.40M | $1.04 | — |
News headlines (Yahoo Finance, 1h cache)
Winklevoss-Backed Zcash Treasury Plunges Nearly 40% on ZEC Privacy Bug Concerns
2026-06-05 15:49 · Yahoo
Zcash Outpaces Bitcoin Gains as Key Development Team Raises $25 Million
2026-03-09 20:19 · Yahoo
David Beckham’s Prenetics Ditches Bitcoin Strategy as Santa Rally Fails
2025-12-31 16:57 · Yahoo
Winklevoss-backed Cypherpunk buys $28 million of zcash, now owns 1.7% of supply
2025-12-31 09:50 · Yahoo
Is Zcash the Next Corporate Treasury Play? Cypherpunk Now Holds Nearly 2%
2025-12-30 23:18 · Yahoo
Surveillance is a "Dangerous Experiment" - Zcash Founder Zooko Wilcox on Why Privacy is Actually the Historical Norm
2025-12-10 20:51 · Yahoo
Winklevoss Twins Double Down on Zcash — Hire ZEC Founder Zooko Wilcox as Advisor
2025-12-10 11:02 · Yahoo
Cypherpunk Technologies (CYPH): How a Radical Crypto Pivot Is Shaping Its Current Valuation
2025-11-14 15:16 · Yahoo
Cypherpunk Stock Soars on Zcash Rebrand. Should You Buy the Crypto Penny Stock Here?
2025-11-14 14:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.